UCB: Appointment of Company Secretary15 Dec 2025
The Company has informed Mr. Tanvir Ahmed Siddiqui has been appointed as the Company Secretary of the company with effect from December 14, 2025.
UCB: Q3 Financials16 Oct 2025
(Q3 Un-audited): Consolidated EPS was Tk. 0.21 for July-September 2025 as against Tk. 0.64 for July-September 2024; Consolidated EPS was Tk. 0.32 for January-September 2025 as against Tk. 1.45 for January-September 2024. Consolidated NOCFPS was Tk. 11.89 for January-September 2025 as against Tk. (6.55) for January-September 2024. Consolidated NAV per share was Tk. 26.02 as on September 30, 2025 and Tk. 27.37 as on September 30, 2024. Comparative numbers are restated in line with current number.
UCB: Board Meeting schedule under LR 16(1)09 Oct 2025
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 15, 2025 at 03:00 PM to consider, among others, Un-audited financial statements of the Company for the Third Quarter (Q3) period ended on September 30, 2025.
UCB: BSEC consent for issuance of BDT 8,000 million subordinated bond05 Oct 2025
Refer to the earlier news disseminated by DSE on 22.06.2025, the company has further informed that Bangladesh Securities and Exchange Commission (BSEC) vide its letter dated September 30, 2025 has accorded its consent for issuance of UCB 6th Subordinated Bond (Non-Convertible, Unsecured, Redeemable, Floating Rate) amounting to BDT 8,000 million through private placement, subject to compliance with applicable laws and conditions imposed by BSEC.
UCB: Q2 Financials29 Jul 2025
(Q2 Un-audited): Consolidated EPS was Tk. 0.08 for April-June 2025 as against Tk. 0.41 for April-June 2024; Consolidated EPS was Tk. 0.12 for January-June 2025 as against Tk. 0.82 for January-June 2024; Consolidated NOCFPS was Tk. 13.33 for January-June 2025 as against Tk. 6.46 for January-June 2024. Consolidated NAV per share was Tk. 25.74 as on June 30, 2025 and Tk. 27.33 as on June 30, 2024.
UCB: Board Meeting schedule under LR 16(1)22 Jul 2025
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 28, 2025 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended June 30, 2025.
UCB: Resumption after Record Date29 Jun 2025
Trading of the shares of the company will resume on 30.06.2025.
UCB: Credit Rating Result26 Jun 2025
Emerging Credit Rating Limited (ECRL) has assigned Surveillance rating to the Company as "AA" in the long term and "ST-2" in the short term along with a Negative outlook based on audited financial statements up to December 31, 2024 and other relevant quantitative as well as qualitative information up to the date of rating.
UCB: Suspension for Record Date26 Jun 2025
Trading of the shares of the company will remain suspended on record date i.e. 29.06.2025
UCB: Spot News24 Jun 2025
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle from 25.06.2025 to 26.06.2025 and trading of the shares will remain suspended on record date i.e., 29.06.2025.
UCB: Regarding issuance of sixth subordinated bond of Tk. 1,000 crore22 Jun 2025
The company has informed that the Board of Directors of the company has approved issuance of UCB Sixth Subordinated Bond of Tk. 1,000 crore in its meeting held on June 19, 2025 subject to approval of concerned regulatory authorities.
UCB: Basis for Qualified Opinion and Other Matter19 Jun 2025
The auditor of the company has given the "Basis for Qualified Opinion" and "Other Matter" paragraphs in the Auditor's Report of the company for the year ended December 31, 2024. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/UCB_2024.pdf
UCB: Q1 Financials01 Jun 2025
(Q1 Un-audited): Consolidated EPS was Tk. 0.04 for January-March 2025 as against Tk. 0.42 (restated) for January-March 2024. Consolidated NOCFPS was Tk. 7.06 for January-March 2025 as against Tk. (4.76) (restated) for January-March 2024. Consolidated NAV per share was Tk. 26.11 as on March 31, 2025 and Tk. 26.53 (restated) as on March 31, 2024. Reasons for deviation in EPS, NOCFPS and NAVPS: (cont.)
UCB: Dividend Declaration01 Jun 2025
The Board of Directors has recommended No dividend for the year ended December 31, 2024. Date of AGM: 31.07.2025, Time: 9:00 AM, Venue: To be notified in due course via official notice. Record Date: 29.06.2025. The Company has also reported Consolidated EPS of Tk. 0.05, Consolidated NAV per share of Tk. 26.42 and Consolidated NOCFPS of Tk. (1.93) for the year ended December 31, 2024 (cont.1)
UCB: Price Limit Open01 Jun 2025
There will be no price limit on the trading of the shares of the Company today (01.06.2025) following its corporate declaration.
UCB: Decision to Increase Authorized Capital01 Jun 2025
The Board of Directors of the Bank has decided to increase the Authorized Capital of the Bank from BDT 2500,00,00,000 (Taka Twenty-five Hundred crore) to BDT 5000,00,00,000 (Five Thousand Crore) subject to approval of the shareholders in the 42nd Annual General Meeting of the Bank and regulatory authorities.
UCB: Decision for issuance of Right Shares01 Jun 2025
The Board has recommended enhancing the Bank's core capital through the issuance of Right Shares as follows: Rights Ratio- 2:1 (1 Right Share for every 2 existing shares) and Offer Price: BDT 10 (Ten) per share
UCB: Issuance of Fresh Shares to Strategic Investor01 Jun 2025
To further strengthen the Bank's core capital, the Board has approved the issuance of fresh shares to a strategic investor under the following terms- Proposed Capital to be Raised: Equivalent to 50% of the Bank's audited paid-up capital as of December 31, 2024 and Offer Price: To be determined through negotiation and disclosed in due course
UCB: Reschedule of Board Meeting under LR 19(1)22 May 2025
The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on May 29, 2025 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2024.
UCB: Reschedule of Board Meeting under LR 16(1)22 May 2025
The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on May 29, 2025 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2025.